company background image
REG logo

Regis Healthcare ASX:REG Stock Report

Last Price

AU$6.09

Market Cap

AU$1.8b

7D

-6.2%

1Y

88.5%

Updated

20 Dec, 2024

Data

Company Financials +

REG Stock Overview

Engages in the provision of residential aged care services in Australia. More details

REG fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

Regis Healthcare Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Regis Healthcare
Historical stock prices
Current Share PriceAU$6.09
52 Week HighAU$6.95
52 Week LowAU$3.10
Beta1.49
1 Month Change-5.43%
3 Month Change2.70%
1 Year Change88.54%
3 Year Change226.54%
5 Year Change147.56%
Change since IPO51.49%

Recent News & Updates

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Dec 20
Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12
Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Recent updates

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Dec 20
Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12
Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02
Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21
At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28
Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18
Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Aug 29
Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Mar 01
Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Oct 27
Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26
Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25
Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27
Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09
Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10
Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10
At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14
Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02
Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Shareholder Returns

REGAU HealthcareAU Market
7D-6.2%-3.1%-2.0%
1Y88.5%-6.6%7.8%

Return vs Industry: REG exceeded the Australian Healthcare industry which returned -6.6% over the past year.

Return vs Market: REG exceeded the Australian Market which returned 7.8% over the past year.

Price Volatility

Is REG's price volatile compared to industry and market?
REG volatility
REG Average Weekly Movement4.2%
Healthcare Industry Average Movement5.6%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: REG has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: REG's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199411,000Linda Mellorswww.regis.com.au

Regis Healthcare Limited engages in the provision of residential aged care services in Australia. It provides aged care services, including ageing-in-place, respite care, specialist dementia care, and palliative care services through operation of aged care homes located in Victoria, Queensland, New South Wales, South Australia, Tasmania, Northern Territory and Western Australia. The company also offers home care services, such as personal care, nursing, help around your home, transport, shopping, companionship, overnight sleepovers, cleaning, and cooking and meal preparation.

Regis Healthcare Limited Fundamentals Summary

How do Regis Healthcare's earnings and revenue compare to its market cap?
REG fundamental statistics
Market capAU$1.83b
Earnings (TTM)-AU$21.41m
Revenue (TTM)AU$1.01b

1.8x

P/S Ratio

-85.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
REG income statement (TTM)
RevenueAU$1.01b
Cost of RevenueAU$838.80m
Gross ProfitAU$175.25m
Other ExpensesAU$196.66m
Earnings-AU$21.41m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.071
Gross Margin17.28%
Net Profit Margin-2.11%
Debt/Equity Ratio0%

How did REG perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

-182%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Regis Healthcare Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
William DunlopBofA Global Research
David StantonCLSA